68Ga-PSMA PET/CT诊断COVID-19患者的气管炎
Tracheitis Diagnosed With 68 Ga-PSMA PET/CT in a Patient With COVID-19.
PubMed 文献 · Clin Nucl Med · 2022-05-27
一名57岁新诊断前列腺癌的无症状男性在68Ga-PSMA PET/CT上显示气管弥漫性摄取增高,双肺未见提示肺炎的磨玻璃密度影;PET/CT后2天出现症状,经实时聚合酶链反应确诊为冠状病毒病2019。
要点
- 无症状COVID-19患者可在68Ga-PSMA PET/CT上表现为气管弥漫性摄取增高。
- 该患者PET/CT时双肺未见提示肺炎的磨玻璃密度影。
- PET/CT后2天出现症状并经实时聚合酶链反应确诊COVID-19。
核心结论
- 68Ga-PSMA PET/CT可在无症状COVID-19患者中显示气管弥漫性摄取增高。
研究设计与样本
- 本文为个案报告,报告一名57岁新诊断前列腺癌患者接受68Ga-PSMA PET/CT检查。
主要发现
- 患者影像时无症状,PET/CT显示气管弥漫性68Ga-PSMA摄取增高。
- PET/CT时双肺未见提示肺炎的磨玻璃密度影。
- PET/CT后2天出现症状,经实时聚合酶链反应确诊冠状病毒病2019。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 57-year-old man with newly diagnosed with prostate cancer was admitted to our department for 68 Ga-prostate-specific membrane antigen PET/CT imaging. The patient, who was asymptomatic at the time of imaging, had increased diffuse 68 Ga-prostate-specific membrane antigen uptake in the trachea on PET/CT. No ground-glass density suggestive of pneumonia in both lungs was observed. The patient, whose symptoms developed 2 days after PET/CT imaging, was diagnosed with coronavirus disease 2019 by real-time polymerase chain reaction.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Aksu A, Bozkurt K, Yılmaz B, et al. Tracheitis Diagnosed With 68 Ga-PSMA PET/CT in a Patient With COVID-19. Clin Nucl Med. 2022. PMID: 35619207. doi:10.1097/RLU.0000000000004288
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。